Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up have?
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up has 431 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up published?
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up has 2016 year in the ScholarIQ index.
What is the open-access status of Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up?
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up has bronze oa status in the ScholarIQ index.
What is the DOI of Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up?
The DOI for Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up is on the source record.
What is the PMID of Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up?
The PMID for Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up is on the source record.
What is the OpenAlex record for Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up?
The OpenAlex for Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up is on the source record.